Previous work has suggested an association between diagnostic uncertainty and the use of nonspecific diagnostic billing codes. We sought to evaluate differences in emergency department (ED) return visits among children discharged from the ED with specific and nonspecific discharge diagnosis codes.
We performed a retrospective study including children (aged <18 years) discharged from 40 pediatric EDs between July 2021 and June 2022. Our primary and secondary outcomes were 7-day and 30-day ED return visits, respectively. Our predictor of interest was diagnosis, classified as nonspecific (only signs/symptoms diagnoses, e.g., “cough”) or specific (≥1 specific diagnosis, e.g., “pneumonia”). We evaluated for associations using Cox proportional hazard models adjusted for race/ethnicity, payer status, age, medical complexity, and neighborhood opportunity.
Among 1870100 discharged children, 7-day return visits occurred in 73956 (4.0%); of these, 15.8% had nonspecific discharge diagnoses. The adjusted hazard ratio (aHR) of a return visit among children with a nonspecific diagnosis on their index visit was 1.08 (95% confidence interval, 1.06–1.10). Nonspecific diagnoses with the highest aHR of return visits were for fever, convulsions, digestive system, abdominal signs/symptoms, and headache. Respiratory and emotional/behavior signs or symptoms had a lower aHR of 7-day return visits. The aHR of nonspecific diagnosis on 30-day return visits was 1.01 (95% confidence interval 1.01–1.03).
Children with nonspecific diagnoses discharged from the ED had distinct patterns of health care utilization compared with those having specific diagnoses. Further research is required to evaluate the role of diagnostic uncertainty with diagnosis code application in the ED.
Diagnostic uncertainty may be defined as a “subjective perception of an inability to provide an accurate explanation of the patient’s health problem.”1 Diagnostic uncertainty is an important priority in pediatric safety,2 with noted challenges in a variety of pediatric settings.3–6 In the emergency department (ED), clinicians must balance concerns of risk tolerance, diagnostic testing stewardship, and timeliness, which may preclude the definitive identification of a diagnosis. Furthermore, clinicians must maintain effective communication and expectations with families in situations where a definitive diagnosis cannot be made.3,6
Clinicians and coders are required to apply diagnostic codes to reflect a patient’s condition. In children with diagnostic uncertainty, the selection of diagnosis codes is challenging, given that coding systems are based on a specific definition. In situations with diagnostic uncertainty, physicians may instead use nonspecific diagnoses (such as “cough” or “abdominal pain”) that are primarily symptom- or sign-based, and which are provided within the International Classification of Disease, 10th revision, Clinical Modification (ICD-10-CM), coding structure. Nonspecific diagnoses may also be used in other situations, such as when there is insufficient disease progression limiting the ability to determine accurate diagnosis or targeted diagnostic workup, when a physician wishes to prevent misdiagnosis or premature closure, or because of factors related to the underlying disease process. Some recent literature suggests a strong association between the use of ambiguous or nonspecific diagnosis codes and diagnostic uncertainty. Marshall et al describe a case control study which demonstrated an association between a nonspecific primary diagnosis code and diagnostic uncertainty among children admitted to the hospital.7 In that study, a nonspecific diagnosis had an adjusted odds ratio of 8.0 for diagnostic uncertainty (95% confidence interval [CI] 5.7–11.2) relative to those with a specific diagnosis.7 Children admitted with an uncertain diagnosis had longer hospital length of stays and more frequently required subspecialty consultation, transfer, and readmission. Another study reported that a discrepancy between admission and discharge diagnoses, typically where the former was symptom-based, was associated with diagnostic uncertainty among hospitalized adults.8 These findings provide an avenue to evaluate the association with diagnostic uncertainty and health care utilization using multicenter administrative data sets.
The role of diagnostic uncertainty and its implications for postdischarge care requirements for children in the ED remains unexplored. Children with diagnostic uncertainty may be at higher risk of having unscheduled return visits. We sought to evaluate the role of a nonspecific diagnosis on return visits among children discharged from the ED.
Methods
Data Source
We performed a retrospective study from 40 US hospitals which contribute data to the Pediatric Health Information System (PHIS), a database containing administrative data from US children’s hospitals affiliated with the Children’s Hospital Association (Lenexa, KS). This study was approved by our institutional review board.
Patient Inclusion
We included children (aged <18 years) discharged from the ED between July 1, 2021, to June 30th, 2022. We identified the first ED encounter per each unique patient during the study period, defined as the “index encounter.” We excluded patients with in-ED mortality and patients with a disposition status as left without being seen. We also excluded patients who had only billing discharge diagnosis codes (as ICD-10-CM codes) starting with V to Y and Z. Diagnosis codes of V to Y indicate external causes of morbidity (such as cause of injury or location of injury). Codes starting with Z describe factors influencing health status and contact with health services, such as do not resuscitate status or family history. We excluded these classes of diagnoses and neither can be considered as either specific or nonspecific diagnoses.
Outcomes and Predictors
Our primary and secondary outcomes of interest were ED return visits within 7 and 30 days of the index encounter, respectively.9 Our predictor of interest was diagnosis, categorized as nonspecific or specific. Nonspecific diagnoses were defined as having all (primary and any secondary) ICD-10-CM codes starting with R (nondisease-based general symptoms and signs; (eg, cough). We further subcategorized these patients using the principal ICD-10-CM code by section. The section for “general symptoms and signs” (R50–R69) was further divided by individual codes (eg, R50 for fever). The ICD-10-CM section for cardiorespiratory abnormalities was divided into subcategories for cardiac and respiratory abnormalities. Subcategories occurring in <0.1% were grouped into an “other” category (Supplemental Table 4). Patients with specific diagnoses had at least 1 specific diagnosis (Fig 1). We similarly classified return visits as having a specific or nonspecific diagnosis.
Data Acquisition
We acquired variables known to be associated with return visits to develop adjusted models,10–12 including payer status (public, private, other, or unknown)11 ; race (non-Hispanic white, non-Hispanic Black, Hispanic/Latino, and others/>1); presence of a chronic complex condition (CCC, using criteria by Feudtner et al)13 ; Child Opportunity Index (COI; v2.0)14 ; and age (infant [aged <1 year], toddler [aged 1–3 years], child [aged 4–11 years], and adolescent [aged ≥12 years]). We included the variables of race and ethnicity on the basis of previous research demonstrating an association between these social constructs and return visits.9,15,16
Analytic Approach
We described our study sample overall and by each outcome. We performed time-to-event analysis, considering encounters after the outcome window as right-censored. We calculated the median time to return visit among children who had a nonspecific diagnosis and a specific diagnosis on their index visit and compared these proportions with the log-rank test. We compared the proportion hospitalized on their return visit using the χ2 test. We identified the proportion children with a nonspecific diagnosis on their index visit who had a nonspecific diagnosis on their return visit. We evaluated the most common pairs of diagnoses on index and return visits among children with a nonspecific diagnosis on their index visit. To evaluate the association between nonspecific diagnoses and return visits, we developed a Cox proportional hazard model for each outcome. These models were developed by (1) considering nonspecific diagnoses as a single category, and (2) dividing nonspecific diagnoses into subcategories. The presence of a specific diagnosis was used as the reference group. We expressed our results as adjusted hazard ratios (aHRs) with 95% CI. Analyses were performed using R, v4.1.2 (R Foundation for Statistical Computing, Vienna, Austria).
Additional Analyses
First, we used generalized linear mixed models to evaluate the association between nonspecific diagnosis and return visits, using hospital as a random effect. Second, we repeated our analysis when defining nonspecific diagnosis as the presence of a nonspecific diagnosis only on the basis of their primary diagnosis (disregarding secondary diagnoses).7 Third, to classify diagnoses into broader groupings for a sensitivity analysis, we classified index and return visit primary diagnoses using the Diagnosis and Grouping System, a consensus-derived classification scheme which classifies diagnoses into 21 major groups.17 We repeated modeling using an outcome defined as a return visit in which the diagnosis group of the index and return visit matched. Fourth, because the application of diagnosis codes among children with medical complexity may differ from those without these conditions, we performed our analysis after removing patients with CCCs from our sample.
Results
Inclusion and Demographics
We identified 2 580 354 ED encounters from 1 914 182 unique patients during the study period. After subsequent exclusions, we identified 1 870 100 children discharged from the ED as index visits (Fig 2). A total of 73 956 (4.0%) had a 7-day return visit and 151 410 (8.1%) had a 30-day return visit. A nonspecific diagnosis was present among 294 701 (15.8%) index visits. Demographics are provided in Table 1.
Demographics of the Study Sample, Overall and by Primary and Secondary Outcomes
Variable . | Overall Sample (Column %) . | Number of 7-d Return Visits With Variable (Row % of Index Patients With This Variable) . | Number of 30-d Return Visits With Variable (Row % of Index Patients With This Variable) . |
---|---|---|---|
Overall | 1 870 100 | 73 956 (4.0) | 151 410 (8.1) |
Primary diagnosis | |||
Specific disease | 1 575 399 (84.2) | 61 514 (3.9) | 127 325 (8.1) |
Presence of any nonspecific disease | 294 701 (15.8) | 12 442 (4.2) | 24 085 (8.2) |
Subcategories of nonspecific disease | |||
Digestive system and abdomen | 105 181 (5.6) | 4582 (4.4) | 8406 (8) |
Fever of other and unknown origin | 55 490 (3.0) | 3211 (5.8) | 5157 (9.3) |
Respiratory system | 55 508 (3.0) | 1869 (3.4) | 4390 (7.9) |
Cognition, perception, emotional state and behavior | 15 603 (0.8) | 433 (2.8) | 1109 (7.1) |
Convulsions, not elsewhere classified | 12 741 (0.7) | 614 (4.8) | 1198 (9.4) |
Skin and subcutaneous tissue | 11 264 (0.6) | 413 (3.7) | 893 (7.9) |
Headache | 9632 (0.5) | 367 (3.8) | 708 (7.4) |
Syncope and collapse | 7764 (0.4) | 157 (2) | 348 (4.5) |
Other general symptoms and signs | 5471 (0.3) | 214 (3.9) | 600 (11) |
Genitourinary system | 3978 (0.2) | 134 (3.4) | 294 (7.4) |
Nervous and musculoskeletal systems | 3226 (0.2) | 122 (3.8) | 248 (7.7) |
Circulatory system | 2212 (0.1) | 69 (3.1) | 160 (7.2) |
Symptoms and signs concerning food and fluid intake | 1987 (0.1) | 96 (4.8) | 211 (10.6) |
Enlarged lymph nodes | 1443 (0.1) | 57 (4) | 128 (8.9) |
Malaise | 1107 (0.1) | 41 (3.7) | 87 (7.9) |
Abnormal findings on examination of blood, without diagnosis | 741 (0.0) | 28 (3.8) | 62 (8.4) |
Abnormal findings on examination of urine, without diagnosis | 381 (0.0) | 7 (1.8) | 20 (5.2) |
Other | 972 (0.1) | 28 (2.9) | 66 (6.8) |
CCCs | 64 076 (3.4) | 4368 (6.8) | 9308 (14.5) |
Age group | |||
Infant | 266 979 (14.3) | 16 173 (6.1) | 33 122 (12.4) |
Toddler | 510 473 (27.3) | 22 440 (4.4) | 46 009 (9) |
Child | 679 484 (36.3) | 21 119 (3.1) | 43 265 (6.4) |
Adolescent | 413 164 (22.1) | 14 224 (3.4) | 29 014 (7) |
Payer status | |||
Public | 1 127 784 (60.3) | 47 434 (4.2) | 102 761 (9.1) |
Commercial | 623 035 (33.3) | 22 425 (3.6) | 40 647 (6.5) |
Other | 116 105 (6.2) | 3993 (3.4) | 7794 (6.7) |
Unknown | 3176 (0.2) | 104 (3.3) | 208 (6.5) |
COI | |||
Very high | 311 651 (16.7) | 11 388 (3.7) | 21 160 (6.8) |
High | 368 565 (19.7) | 14 795 (4) | 28 851 (7.8) |
Moderate | 273 829 (14.6) | 11 038 (4) | 22 249 (8.1) |
Low | 427 866 (22.9) | 17 301 (4) | 35 946 (8.4) |
Very low | 482 798 (25.8) | 19 238 (4) | 42 828 (8.9) |
Race and ethnicity | |||
White non-Hispanic | 661 089 (35.4) | 25 860 (3.9) | 48 685 (7.4) |
Black non-Hispanic | 435 400 (23.3) | 16 978 (3.9) | 38 638 (8.9) |
Hispanic or Latino | 570 157 (30.5) | 23 530 (4.1) | 48 771 (8.6) |
Other or >1 | 160 026 (8.6) | 6205 (3.9) | 12 536 (7.8) |
Variable . | Overall Sample (Column %) . | Number of 7-d Return Visits With Variable (Row % of Index Patients With This Variable) . | Number of 30-d Return Visits With Variable (Row % of Index Patients With This Variable) . |
---|---|---|---|
Overall | 1 870 100 | 73 956 (4.0) | 151 410 (8.1) |
Primary diagnosis | |||
Specific disease | 1 575 399 (84.2) | 61 514 (3.9) | 127 325 (8.1) |
Presence of any nonspecific disease | 294 701 (15.8) | 12 442 (4.2) | 24 085 (8.2) |
Subcategories of nonspecific disease | |||
Digestive system and abdomen | 105 181 (5.6) | 4582 (4.4) | 8406 (8) |
Fever of other and unknown origin | 55 490 (3.0) | 3211 (5.8) | 5157 (9.3) |
Respiratory system | 55 508 (3.0) | 1869 (3.4) | 4390 (7.9) |
Cognition, perception, emotional state and behavior | 15 603 (0.8) | 433 (2.8) | 1109 (7.1) |
Convulsions, not elsewhere classified | 12 741 (0.7) | 614 (4.8) | 1198 (9.4) |
Skin and subcutaneous tissue | 11 264 (0.6) | 413 (3.7) | 893 (7.9) |
Headache | 9632 (0.5) | 367 (3.8) | 708 (7.4) |
Syncope and collapse | 7764 (0.4) | 157 (2) | 348 (4.5) |
Other general symptoms and signs | 5471 (0.3) | 214 (3.9) | 600 (11) |
Genitourinary system | 3978 (0.2) | 134 (3.4) | 294 (7.4) |
Nervous and musculoskeletal systems | 3226 (0.2) | 122 (3.8) | 248 (7.7) |
Circulatory system | 2212 (0.1) | 69 (3.1) | 160 (7.2) |
Symptoms and signs concerning food and fluid intake | 1987 (0.1) | 96 (4.8) | 211 (10.6) |
Enlarged lymph nodes | 1443 (0.1) | 57 (4) | 128 (8.9) |
Malaise | 1107 (0.1) | 41 (3.7) | 87 (7.9) |
Abnormal findings on examination of blood, without diagnosis | 741 (0.0) | 28 (3.8) | 62 (8.4) |
Abnormal findings on examination of urine, without diagnosis | 381 (0.0) | 7 (1.8) | 20 (5.2) |
Other | 972 (0.1) | 28 (2.9) | 66 (6.8) |
CCCs | 64 076 (3.4) | 4368 (6.8) | 9308 (14.5) |
Age group | |||
Infant | 266 979 (14.3) | 16 173 (6.1) | 33 122 (12.4) |
Toddler | 510 473 (27.3) | 22 440 (4.4) | 46 009 (9) |
Child | 679 484 (36.3) | 21 119 (3.1) | 43 265 (6.4) |
Adolescent | 413 164 (22.1) | 14 224 (3.4) | 29 014 (7) |
Payer status | |||
Public | 1 127 784 (60.3) | 47 434 (4.2) | 102 761 (9.1) |
Commercial | 623 035 (33.3) | 22 425 (3.6) | 40 647 (6.5) |
Other | 116 105 (6.2) | 3993 (3.4) | 7794 (6.7) |
Unknown | 3176 (0.2) | 104 (3.3) | 208 (6.5) |
COI | |||
Very high | 311 651 (16.7) | 11 388 (3.7) | 21 160 (6.8) |
High | 368 565 (19.7) | 14 795 (4) | 28 851 (7.8) |
Moderate | 273 829 (14.6) | 11 038 (4) | 22 249 (8.1) |
Low | 427 866 (22.9) | 17 301 (4) | 35 946 (8.4) |
Very low | 482 798 (25.8) | 19 238 (4) | 42 828 (8.9) |
Race and ethnicity | |||
White non-Hispanic | 661 089 (35.4) | 25 860 (3.9) | 48 685 (7.4) |
Black non-Hispanic | 435 400 (23.3) | 16 978 (3.9) | 38 638 (8.9) |
Hispanic or Latino | 570 157 (30.5) | 23 530 (4.1) | 48 771 (8.6) |
Other or >1 | 160 026 (8.6) | 6205 (3.9) | 12 536 (7.8) |
COI missing in 5391 (0.3%); race and ethnicity missing in 43 428 (2.3%). Other includes: abnormal findings on diagnostic imaging and in function studies, without diagnosis (R90–R94, n = 346); edema not elsewhere classified (R60, n = 317); lack of expected normal physiologic development (R62, n = 231); unspecified pain (R52, n = 195); symptoms and signs involving speech and voice (R47–R49, n = 178); abnormal findings on other body fluids (R83–R89, n = 158); hemorrhage not elsewhere classified (R58, n = 114); hyperhidrosis (R61, n = 50); unspecified illness (R69, n = 13); systemic inflammation or infection (R65, n = 7); unspecified shock (R57, n = 6); other abnormal tumor markers (R97–R97; n = 1); and ill-defined and unknown cause of mortality (R99, n = 2).
Seven-Day Return Visits
Seven-day return visits were slightly higher among those with a nonspecific primary diagnosis on their index visit (4.2% vs 3.9%; P < .01 by log-rank test). The median time to return visit was the same (2 days, interquartile range [IQR] 1–4 days) among patients with a nonspecific and a specific diagnosis on their index visit. For children with a 7-day return visit, a similar proportion of infants were hospitalized among those with a nonspecific diagnosis (22.2%) and with a pecific diagnosis (22.0%) on their index visit (P = .58). A nonspecific diagnosis on the return visit occurred in 85.7% and 14.3% of children who had a nonspecific diagnosis and a specific diagnosis at the time of their index visit, respectively. The most common pairings of diagnoses with a specific diagnosis on return visits were those with fever or vomiting. When 7-day return visits resulted in another nonspecific diagnosis, the same principal diagnosis was frequently used (Table 2).
Most Common Pairings of Nonspecific Diagnoses on Index Visits and Diagnoses on 7-Day Return Visits
Initial Diagnosis (ICD-10-CM Code) . | Return Visit Diagnosis (ICD-10-CM Code) . | % of Pairings . | Median Time to Follow Up (d) . | % Admitted on Return Visit . |
---|---|---|---|---|
Nonspecific diagnosis on index visits and specific diagnosis on return visit | ||||
Fever, unspecified (R509) | Acute upper respiratory infection, unspecified (J069) | 3.0 | 2 | 2.6 |
Vomiting, unspecified (R1110) | Noninfective gastroenteritis and colitis, unspecified (K529) | 2.3 | 2 | 12.6 |
Vomiting, unspecified (R1110) | Dehydration (E860) | 1.9 | 2 | 66.4 |
Fever, unspecified (R509) | Viral infection, unspecified (B349) | 1.8 | 2 | 8.8 |
Fever, unspecified (R509) | COVID-19, virus identified (U071) | 1.6 | 2 | 23.2 |
Fever, unspecified (R509) | Unspecified viral infection characterized by skin and mucous membrane lesions (B09) | 1.4 | 3 | 1.9 |
Vomiting, unspecified (R1110) | Viral intestinal infection, unspecified (A084) | 1.4 | 2 | 35.8 |
Fever, unspecified (R509) | Dehydration (E860) | 1.0 | 2 | 71.3 |
Fever, unspecified (R509) | Enteroviral vesicular stomatitis with exanthem (B084) | 0.9 | 2 | 2.8 |
Unspecified abdominal pain (R109) | Constipation, unspecified (K5900) | 0.9 | 2 | 9.1 |
Nonspecific diagnosis on index visits and nonspecific diagnosis on return visit | ||||
Fever, unspecified (R509) | Fever, unspecified (R509) | 12.7 | 2 | 7.7 |
Vomiting, unspecified (R1110) | Vomiting, unspecified (R1110) | 4.9 | 2 | 3.4 |
Unspecified convulsions (R569) | Unspecified convulsions (R569) | 2.2 | 3 | 26.2 |
Headache, unspecified (R519) | Headache, unspecified (R519) | 1.9 | 3 | 5.5 |
Unspecified abdominal pain (R109) | Unspecified abdominal pain (R109) | 2.0 | 2 | 0.0 |
Right lower quadrant pain (R1031) | Right lower quadrant pain (R1031) | 1.6 | 2 | 10.4 |
Fever, unspecified (R509) | Bacteremia (R7881) | 1.5 | 1 | 40.6 |
Vomiting, unspecified (R1110) | Fever, unspecified (R509) | 1.3 | 2 | 3.1 |
Diarrhea, unspecified (R197) | Diarrhea, unspecified (R197) | 1.3 | 3 | 6.5 |
Vomiting, unspecified (R1110) | Diarrhea, unspecified (R197) | 1.3 | 3 | 4.8 |
Initial Diagnosis (ICD-10-CM Code) . | Return Visit Diagnosis (ICD-10-CM Code) . | % of Pairings . | Median Time to Follow Up (d) . | % Admitted on Return Visit . |
---|---|---|---|---|
Nonspecific diagnosis on index visits and specific diagnosis on return visit | ||||
Fever, unspecified (R509) | Acute upper respiratory infection, unspecified (J069) | 3.0 | 2 | 2.6 |
Vomiting, unspecified (R1110) | Noninfective gastroenteritis and colitis, unspecified (K529) | 2.3 | 2 | 12.6 |
Vomiting, unspecified (R1110) | Dehydration (E860) | 1.9 | 2 | 66.4 |
Fever, unspecified (R509) | Viral infection, unspecified (B349) | 1.8 | 2 | 8.8 |
Fever, unspecified (R509) | COVID-19, virus identified (U071) | 1.6 | 2 | 23.2 |
Fever, unspecified (R509) | Unspecified viral infection characterized by skin and mucous membrane lesions (B09) | 1.4 | 3 | 1.9 |
Vomiting, unspecified (R1110) | Viral intestinal infection, unspecified (A084) | 1.4 | 2 | 35.8 |
Fever, unspecified (R509) | Dehydration (E860) | 1.0 | 2 | 71.3 |
Fever, unspecified (R509) | Enteroviral vesicular stomatitis with exanthem (B084) | 0.9 | 2 | 2.8 |
Unspecified abdominal pain (R109) | Constipation, unspecified (K5900) | 0.9 | 2 | 9.1 |
Nonspecific diagnosis on index visits and nonspecific diagnosis on return visit | ||||
Fever, unspecified (R509) | Fever, unspecified (R509) | 12.7 | 2 | 7.7 |
Vomiting, unspecified (R1110) | Vomiting, unspecified (R1110) | 4.9 | 2 | 3.4 |
Unspecified convulsions (R569) | Unspecified convulsions (R569) | 2.2 | 3 | 26.2 |
Headache, unspecified (R519) | Headache, unspecified (R519) | 1.9 | 3 | 5.5 |
Unspecified abdominal pain (R109) | Unspecified abdominal pain (R109) | 2.0 | 2 | 0.0 |
Right lower quadrant pain (R1031) | Right lower quadrant pain (R1031) | 1.6 | 2 | 10.4 |
Fever, unspecified (R509) | Bacteremia (R7881) | 1.5 | 1 | 40.6 |
Vomiting, unspecified (R1110) | Fever, unspecified (R509) | 1.3 | 2 | 3.1 |
Diarrhea, unspecified (R197) | Diarrhea, unspecified (R197) | 1.3 | 3 | 6.5 |
Vomiting, unspecified (R1110) | Diarrhea, unspecified (R197) | 1.3 | 3 | 4.8 |
COVID-19, coronavirus disease 2019.
The aHR of having a 7-day return visit was higher among those with a nonspecific diagnosis on their index encounter (aHR 1.08, 95% CI 1.06–1.10). In a model which included subcategories, nonspecific diagnoses with the highest aHR of a return visit were fever (1.36, 95% CI 1.31–1.41), convulsions (1.27, 95% CI 1.17–1.38), digestive system and abdomen (1.17, 95% CI 1.13–1.20), and headache (1.17, 95% CI 1.05–1.29). Respiratory disorders (0.84, 95% CI 0.80–0.88), emotional state and behavior (0.84, 95% CI 0.76–0.92), and other general symptoms and signs (0.69, 95% CI 0.60–0.80) had lower aHRs of return visits (Table 3).
Emergency Department Return Visits Characteristics and Odds Ratios From Univariable and Multivariable Cox Proportional Hazard Models
. | 7-d Return Visit . | 30-d Return Visit . | ||
---|---|---|---|---|
Variable . | Univariable HR . | Multivariable HR . | Univariable HR . | Multivariable HR . |
Primary diagnosis | ||||
Specific disease | Ref | Ref | Ref | Ref |
Subcategory of nonspecific disease | ||||
Digestive system and abdomen | 1.12 (1.09–1.15) | 1.17 (1.13–1.20) | 0.99 (0.97–1.01) | 1.04 (1.02–1.07) |
Fever of other and unknown origin | 1.50 (1.45–1.56) | 1.36 (1.31–1.41) | 1.17 (1.13–1.20) | 1.05 (1.02–1.08) |
Respiratory system | 0.86 (0.82–0.90) | 0.84 (0.80–0.88) | 0.97 (0.95–1.00) | 0.94 (0.92–0.97) |
Cognition, perception, emotional state and behavior | 0.71 (0.64–0.78) | 0.84 (0.76–0.92) | 0.87 (0.82–0.92) | 1.06 (1.00–1.13) |
Convulsions, not elsewhere classified | 1.24 (1.15–1.35) | 1.27 (1.17–1.38) | 1.18 (1.11–1.24) | 1.22 (1.15–1.29) |
Skin and subcutaneous tissue | 0.94 (0.85–1.03) | 0.91 (0.82–1.00) | 0.98 (0.92–1.05) | 0.95 (0.89–1.02) |
Headache | 0.97 (0.88–1.08) | 1.17 (1.05–1.29) | 0.91 (0.84–0.98) | 1.10 (1.02–1.19) |
Syncope and collapse | 0.51 (0.44–0.60) | 0.62 (0.53–0.73) | 0.54 (0.49–0.60) | 0.69 (0.62–0.76) |
Other general symptoms and signs | 1 (0.87–1.14) | 0.69 (0.60–0.80) | 1.36 (1.26–1.48) | 0.95 (0.88–1.04) |
Genitourinary system | 0.86 (0.73–1.02) | 0.92 (0.78–1.09) | 0.91 (0.81–1.02) | 0.99 (0.88–1.11) |
Nervous and musculoskeletal systems | 0.97 (0.81–1.15) | 0.94 (0.78–1.12) | 0.95 (0.84–1.08) | 0.95 (0.83–1.07) |
Circulatory system | 0.80 (0.63–1.01) | 0.85 (0.67–1.08) | 0.89 (0.76–1.04) | 0.98 (0.84–1.15) |
Symptoms and signs concerning food and fluid intake | 1.24 (1.01–1.51) | 1.02 (0.84–1.25) | 1.33 (1.16–1.52) | 1.11 (0.97–1.27) |
Enlarged lymph nodes | 1.01 (0.78–1.31) | 1.12 (0.87–1.46) | 1.1 (0.93–1.31) | 1.22 (1.03–1.45) |
Malaise | 0.94 (0.70–1.28) | 0.98 (0.72–1.35) | 0.97 (0.79–1.20) | 1.07 (0.86–1.32) |
Abnormal findings on examination of blood, without diagnosis | 0.97 (0.67–1.40) | 0.99 (0.68–1.43) | 1.04 (0.81–1.33) | 1.02 (0.79–1.32) |
Abnormal findings on examination of urine, without diagnosis | 0.47 (0.22–0.98) | 0.45 (0.21–0.93) | 0.64 (0.41–0.99) | 0.61 (0.40–0.95) |
Other | 0.73 (0.51–1.06) | 0.71 (0.49–1.02) | 0.83 (0.66–1.06) | 0.8 (0.62–1.02) |
CCS | 1.79 (1.74–1.85) | 1.87 (1.81–1.93) | 1.91 (1.87–1.95) | 1.97 (1.93–2.02) |
Age group | ||||
Infant | Ref | Ref | Ref | Ref |
Toddler | 0.72 (0.70–0.73) | 0.72 (0.70–0.73) | 0.71 (0.70–0.72) | 0.72 (0.71–0.73) |
Child | 0.50 (0.49–0.51) | 0.50 (0.49–0.51) | 0.50 (0.49–0.50) | 0.50 (0.49–0.50) |
Adolescent | 0.56 (0.55–0.57) | 0.56 (0.55–0.57) | 0.55 (0.54–0.56) | 0.55 (0.54–0.56) |
Payer status | ||||
Public | Ref | Ref | Ref | Ref |
Commercial | 0.85 (0.84–0.87) | 0.87 (0.86–0.89) | 0.71 (0.70–0.72) | 0.76 (0.75–0.77) |
Other | 0.81 (0.79–0.84) | 0.82 (0.80–0.85) | 0.73 (0.71–0.75) | 0.75 (0.73–0.77) |
Unknown | 0.78 (0.64–0.94) | 0.75 (0.61–0.92) | 0.71 (0.62–0.81) | 0.68 (0.59–0.79) |
COI | ||||
Very high | Ref | Ref | Ref | Ref |
High | 1.10 (1.07–1.13) | 1.04 (1.02–1.07) | 1.16 (1.14–1.18) | 1.05 (1.04–1.07) |
Moderate | 1.10 (1.08–1.13) | 1.02 (1.00–1.05) | 1.2 (1.18–1.23) | 1.05 (1.03–1.07) |
Low | 1.11 (1.08–1.13) | 1.02 (0.99–1.04) | 1.24 (1.22–1.27) | 1.05 (1.03–1.07) |
Very low | 1.09 (1.07–1.12) | 1.01 (0.99–1.04) | 1.31 (1.29–1.34) | 1.09 (1.07–1.11) |
Race and ethnicity | ||||
White non-Hispanic | Ref | Ref | Ref | Ref |
Black non-Hispanic | 1.00 (0.98–1.01) | 0.95 (0.93–0.97) | 1.21 (1.19–1.23) | 1.07 (1.05–1.08) |
Hispanic or Latino | 1.05 (1.04–1.07) | 1.00 (0.99–1.02) | 1.17 (1.15–1.18) | 1.04 (1.03–1.06) |
Other or >1 | 0.99 (0.96–1.02) | 0.95 (0.93–0.98) | 1.06 (1.04–1.09) | 1.00 (0.98–1.02) |
. | 7-d Return Visit . | 30-d Return Visit . | ||
---|---|---|---|---|
Variable . | Univariable HR . | Multivariable HR . | Univariable HR . | Multivariable HR . |
Primary diagnosis | ||||
Specific disease | Ref | Ref | Ref | Ref |
Subcategory of nonspecific disease | ||||
Digestive system and abdomen | 1.12 (1.09–1.15) | 1.17 (1.13–1.20) | 0.99 (0.97–1.01) | 1.04 (1.02–1.07) |
Fever of other and unknown origin | 1.50 (1.45–1.56) | 1.36 (1.31–1.41) | 1.17 (1.13–1.20) | 1.05 (1.02–1.08) |
Respiratory system | 0.86 (0.82–0.90) | 0.84 (0.80–0.88) | 0.97 (0.95–1.00) | 0.94 (0.92–0.97) |
Cognition, perception, emotional state and behavior | 0.71 (0.64–0.78) | 0.84 (0.76–0.92) | 0.87 (0.82–0.92) | 1.06 (1.00–1.13) |
Convulsions, not elsewhere classified | 1.24 (1.15–1.35) | 1.27 (1.17–1.38) | 1.18 (1.11–1.24) | 1.22 (1.15–1.29) |
Skin and subcutaneous tissue | 0.94 (0.85–1.03) | 0.91 (0.82–1.00) | 0.98 (0.92–1.05) | 0.95 (0.89–1.02) |
Headache | 0.97 (0.88–1.08) | 1.17 (1.05–1.29) | 0.91 (0.84–0.98) | 1.10 (1.02–1.19) |
Syncope and collapse | 0.51 (0.44–0.60) | 0.62 (0.53–0.73) | 0.54 (0.49–0.60) | 0.69 (0.62–0.76) |
Other general symptoms and signs | 1 (0.87–1.14) | 0.69 (0.60–0.80) | 1.36 (1.26–1.48) | 0.95 (0.88–1.04) |
Genitourinary system | 0.86 (0.73–1.02) | 0.92 (0.78–1.09) | 0.91 (0.81–1.02) | 0.99 (0.88–1.11) |
Nervous and musculoskeletal systems | 0.97 (0.81–1.15) | 0.94 (0.78–1.12) | 0.95 (0.84–1.08) | 0.95 (0.83–1.07) |
Circulatory system | 0.80 (0.63–1.01) | 0.85 (0.67–1.08) | 0.89 (0.76–1.04) | 0.98 (0.84–1.15) |
Symptoms and signs concerning food and fluid intake | 1.24 (1.01–1.51) | 1.02 (0.84–1.25) | 1.33 (1.16–1.52) | 1.11 (0.97–1.27) |
Enlarged lymph nodes | 1.01 (0.78–1.31) | 1.12 (0.87–1.46) | 1.1 (0.93–1.31) | 1.22 (1.03–1.45) |
Malaise | 0.94 (0.70–1.28) | 0.98 (0.72–1.35) | 0.97 (0.79–1.20) | 1.07 (0.86–1.32) |
Abnormal findings on examination of blood, without diagnosis | 0.97 (0.67–1.40) | 0.99 (0.68–1.43) | 1.04 (0.81–1.33) | 1.02 (0.79–1.32) |
Abnormal findings on examination of urine, without diagnosis | 0.47 (0.22–0.98) | 0.45 (0.21–0.93) | 0.64 (0.41–0.99) | 0.61 (0.40–0.95) |
Other | 0.73 (0.51–1.06) | 0.71 (0.49–1.02) | 0.83 (0.66–1.06) | 0.8 (0.62–1.02) |
CCS | 1.79 (1.74–1.85) | 1.87 (1.81–1.93) | 1.91 (1.87–1.95) | 1.97 (1.93–2.02) |
Age group | ||||
Infant | Ref | Ref | Ref | Ref |
Toddler | 0.72 (0.70–0.73) | 0.72 (0.70–0.73) | 0.71 (0.70–0.72) | 0.72 (0.71–0.73) |
Child | 0.50 (0.49–0.51) | 0.50 (0.49–0.51) | 0.50 (0.49–0.50) | 0.50 (0.49–0.50) |
Adolescent | 0.56 (0.55–0.57) | 0.56 (0.55–0.57) | 0.55 (0.54–0.56) | 0.55 (0.54–0.56) |
Payer status | ||||
Public | Ref | Ref | Ref | Ref |
Commercial | 0.85 (0.84–0.87) | 0.87 (0.86–0.89) | 0.71 (0.70–0.72) | 0.76 (0.75–0.77) |
Other | 0.81 (0.79–0.84) | 0.82 (0.80–0.85) | 0.73 (0.71–0.75) | 0.75 (0.73–0.77) |
Unknown | 0.78 (0.64–0.94) | 0.75 (0.61–0.92) | 0.71 (0.62–0.81) | 0.68 (0.59–0.79) |
COI | ||||
Very high | Ref | Ref | Ref | Ref |
High | 1.10 (1.07–1.13) | 1.04 (1.02–1.07) | 1.16 (1.14–1.18) | 1.05 (1.04–1.07) |
Moderate | 1.10 (1.08–1.13) | 1.02 (1.00–1.05) | 1.2 (1.18–1.23) | 1.05 (1.03–1.07) |
Low | 1.11 (1.08–1.13) | 1.02 (0.99–1.04) | 1.24 (1.22–1.27) | 1.05 (1.03–1.07) |
Very low | 1.09 (1.07–1.12) | 1.01 (0.99–1.04) | 1.31 (1.29–1.34) | 1.09 (1.07–1.11) |
Race and ethnicity | ||||
White non-Hispanic | Ref | Ref | Ref | Ref |
Black non-Hispanic | 1.00 (0.98–1.01) | 0.95 (0.93–0.97) | 1.21 (1.19–1.23) | 1.07 (1.05–1.08) |
Hispanic or Latino | 1.05 (1.04–1.07) | 1.00 (0.99–1.02) | 1.17 (1.15–1.18) | 1.04 (1.03–1.06) |
Other or >1 | 0.99 (0.96–1.02) | 0.95 (0.93–0.98) | 1.06 (1.04–1.09) | 1.00 (0.98–1.02) |
Ref, reference.
Thirty-day Return Visits
Children with a nonspecific diagnosis had a similar proportion of 30-day return visits compared with those with a specific diagnosis (8.6% vs 7.9%; P = .06 by log-rank test). The median time to return visit was 7 days (IQR 2–17) among patients with a nonspecific diagnosis and 8 days (IQR 3–18) among patients with a specific diagnosis on their index visit. A similar proportion of children were admitted to the hospital among those with a nonspecific diagnosis (17.4%) compared with those with a specific diagnosis (16.9%) at the time of their first return visit (P = .09). A nonspecific diagnosis occurred more frequently upon revisit among children with a nonspecific diagnosis on their index visit (86.1%, compared with 13.9% among patients with a specific diagnosis on their index visit). Diagnosis pairings between index and return visits were similar when using a 30-day return visit window as observed for a 7-day window (Supplemental Table 5).
The presence of a nonspecific diagnosis was associated with a slightly higher aHR of a 30-day return visit in a multivariable model (aHR 1.01, 95% CI 1.01–1.03). In models using subcategories of nonspecific diagnoses, many had a higher adjusted odds of a 30-day return visit relative to those with a specific diagnosis. The highest aHRs were among convulsions (1.22, 95% CI 1.15–1.29), enlarged lymph nodes (1.22, 95% CI 1.03–1.45), and headache (1.10, 95% CI 1.02–1.19). Syncope (aHR 0.69, 95% CI 0.62–0.76) and respiratory disease (aHR 0.94, 95% CI 0.92–0.97) had a lower aHR of a 30-day return visit.
Other Variables Associated With Return Visits
Older children had a lower aHR of return visits compared with infants. Commercially insured patients had a lower aHR of return visit compared with publicly insured patients. Children from lower COI neighborhoods had a higher aHR of return visit compared with those from very high COI areas. Black non-Hispanic children had a lower aHR of 7-day return visit compared with white non-Hispanic infants. Black non-Hispanic and Hispanic children had a higher aHR for 30-day return visits compared with white non-Hispanic children.
Use of a Generalized Linear Mixed Model
When using a generalized linear mixed model, the adjusted odds ratio for a child with a nonspecific diagnosis on their index visit was 1.10 (95% CI 1.07–1.12) for a 7-day return visit and 1.03 (95% CI 1.02–1.05) for a 30-day return visit. Models using subcategories resembled the proportional hazard models (Supplemental Table 6).
Changing the Definition Of Nonspecific Diagnoses
When nonspecific diagnoses were determined using the primary discharge diagnosis, a higher proportion (n = 458 995, 24.5%) were classified as having a nonspecific diagnosis. The aHR of a nonspecific diagnosis for 7- and 30-day return visits was higher (aHR 1.15, 95% CI 1.13–1.17 and aHR 1.08, 95% CI 1.07–1.10, respectively). Findings in subcategories were similar to the primary analysis (Supplemental Table 7).
Return Visits Within the Same Diagnosis Category
Return visits occurring within the same category occurred in 37 729 (2.0%) within 7 days and 65 174 (3.5%) within 30 days. The aHR of a nonspecific diagnosis leading to a 7-day and 30-day return visit was 1.16 (95% CI 1.13–1.19) and 1.12 (95% CI 1.10–1.15), respectively. The evaluation within subcategories resembled the primary analysis (Supplemental Table 8).
Return Visits Among Children Without CCCs
When excluding children with CCCs, the aHR for a nonspecific diagnosis to result in a 7-day return visits was 1.09 (95% CI 1.06–1.11) and to a 30-day return visit was 1.02 (95% CI 1.01–1.03). Models performed using subcategories again resembled the primary analysis (Supplemental Table 9).
Discussion
We evaluated the association of a nonspecific diagnosis with pediatric ED return visits. Approximately 15% of children discharged from the ED had a nonspecific diagnosis. Overall, children with nonspecific diagnoses were 8% more likely to have a 7-day return visit.
Our finding of an 8% increased likelihood of a 7-day return visit is small but remains present in adjusted models. This effect varied on the basis of diagnosis and was greater in sensitivity analyses. Marshall et al demonstrated an association among diagnostic uncertainty and a nonspecific primary diagnosis code among admissions.7 Extending these findings to the current study, nonspecific diagnosis coding may be indicative of diagnostic uncertainty by the treating physician. However, this comparison has not been performed in an ED-based population, where priorities of clinicians (such as the establishment of a safe patient disposition, with or without diagnostic certainty) differ from those caring for hospitalized children.7
The higher proportion of return visits among children with nonspecific diagnoses is likely because of several causes. Disease progression may be among the most important, given the high number of children with fever who were later diagnosed with viral syndromes, or children with vomiting later diagnosed with gastroenteritis demonstrated in our pairwise analysis. For many of these pairings, progression occurred along expected lines, suggesting that establishing expectations with patients and discharge teaching may play a role in preventing some unnecessary return visits. Although some patients may have had a missed clinically important diagnosis on their initial visit, this effect is likely minimal based on previous work, suggesting that missed diagnoses accounted for <4% of pediatric ED return visits.18 A qualitative study performed among pediatric emergency medicine and hospitalist providers identified important themes within the diagnostic process, including an appreciation for the “test of time,” prioritizing disposition over diagnosis, and effective communication with families.3 Some potentially unnecessary return visits, suggested in our pairwise analysis, may be mitigated through discussions with primary care providers19 and through multimodal and engaged discharge processes that ensure families have clear expectations about what to expect and when to return to care.20
Certain diagnoses are more clearly linked to a higher aHR of diagnostic uncertainty compared with others. The overall association when evaluating our findings by subcategory suggest that some nonspecific diagnoses (such as fever) have a higher risk of return visit than others (respiratory disorders). Patients with fever, for example, more clearly differentiate into a specific diagnosis over time. One study noted that febrile children who made a return visit had higher temperature elevations and longer durations of fever compared with those who did not have an ED return visit.21 Similarly, a patient with vomiting alone may more fully meet criteria for gastroenteritis after disease progression.
Other findings corroborate previously reported research about ED return visits in children. We found, for example, an association between lower COI areas and return visits, which has been previously reported.10 Our univariable associations with race and ethnicity demonstrated associations with this variable and return visits. However, their effect sizes were lower in adjusted models, suggesting that other factors (such as payer status and neighborhood opportunity) limit the role of race and ethnicity on return visits. Some of these findings may be because of difficulties in outpatient care access reported among Black and Hispanic children.22,23 The association with CCCs and return visits is consistent with the higher degree of hospital-based care required for these patients.12,24
Our findings suggest of important areas for future investigation. Further work is required to establish a connection more definitively between diagnostic uncertainty and diagnosis coding in the ED. The study by Marshall et al used a case-control study with electronic medical record data to ascertain diagnostic uncertainty.7 Granular, and ideally, multisite chart reviews, such as have been performed for pneumonia,25 fever,26 or urinary tract infection,27 will allow for the identification of diagnosis codes most strongly associated with diagnostic uncertainty and provide measures of sensitivity, specificity, and predictive value. In addition, qualitative research will be needed to evaluate how these codes are used in practice by physicians (whether truly for diagnostic uncertainty, expediency, defensive practices, or for other reasons) and to evaluate how a nonspecific diagnosis and diagnostic uncertainty are perceived by patients and families.
Our findings are subject to limitations. Some ED return visits may occur for unrelated reasons from the index visit (e.g., cough, followed by a return visit for a motor vehicle collision). However, previous work has suggested that there is substantial overlap between diagnoses among index and return visits for 3- and 7-day return visits when using Diagnosis and Grouping System groupings, though this decreases more for 30-day return visits.9 Studies which have evaluated individual cases suggest that a variable proportion of ED return visits are for unrelated reasons, ranging between 4% and 30%.18,28,29 We were unable to evaluate return visits to other (non-PHIS) hospitals, which likely underestimates the overall ED return visit proportion.30 Our findings may not generalize to nonpediatric EDs.31 PHIS may have errors related to data abstraction and coding, and does not contain clinical information needed to delineate disease progression versus missed diagnoses. Finally, different hospitals and coders may apply primary and secondary diagnosis codes differently. Despite these limitations, our study provides important information about the potential role of diagnostic uncertainty on pediatric ED return visits.
We used an administrative data set to identify the association between nonspecific diagnoses and ED return visits. Children discharged from the ED with nonspecific diagnoses had more return visits in adjusted models compared with those with specific diagnoses. These findings highlight the need for further research and multimodal approaches to better identify diagnostic uncertainty within medical record data and to ultimately improve care delivery during these complex situations.
FUNDING: No external funding.
CONFLICT OF INTEREST DISCLOSURES: The author has indicated he has no conflicts of interest relevant to this article to disclose.
Dr Ramgopal contributed to conceptualization and design of the study, data analysis, and drafting of the manuscript; and the author approves the final manuscript as submitted and agrees to be accountable for all aspects of the work.
Comments